Knockdown of miR-135a-5p Promotes Mitophagy by Regulating FoxO1/PINK1/Parkin Signaling in Hepatoma Cells Exposed to Oxidative Stress DOI
Zhenchang Wang,

Zhang Wen-fu,

Wu Shanshan

и другие.

Current Proteomics, Год журнала: 2023, Номер 20(3), С. 169 - 183

Опубликована: Июнь 1, 2023

Introduction: Excessive oxidative stress is always associated with hepatic disease, including hepatitis, liver fibrosis, and hepatocellular carcinoma (HCC). Despite this, the intricate molecular processes driving hepatocyte apoptosis due to remain incompletely comprehended. Aim: Consequently, we aimed explore role of miR-135a-5p in hepatoma cells (HepG2/3B). Methods: The assessment protein expression was conducted through western blotting. Furthermore, evaluated RT-qPCR, detection performed using a flow cytometry assay. Result: findings suggest connection between mitochondrial-driven caspase signaling pathways. suppression inhibited apoptotic response triggered by H2O2, reactive oxygen species (ROS) generation, as well decrease mitochondrial membrane potential. Conclusion: Additionally, knockdown promoted mitophagy regulating FoxO1/PINK1/Parkin via targeting FoxO1. To conclude, our study implied that miR- 135a-5p might function probable regulator protects against stress.

Язык: Английский

Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential DOI Creative Commons

Alexander Fuerlinger,

Alina Stockner,

Simon Sedej

и другие.

Cardiovascular Diabetology, Год журнала: 2025, Номер 24(1)

Опубликована: Янв. 18, 2025

Язык: Английский

Процитировано

2

Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications DOI Open Access
Rong Zhou, Zhaoming Zhang, Xinjie Li

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(4), С. 1668 - 1668

Опубликована: Фев. 15, 2025

Metabolic cardiomyopathy, encompassing diabetic and obese is an escalating global health concern, driven by the rising prevalence of metabolic disorders such as insulin resistance, type 1 2 diabetes, obesity. These conditions induce structural functional alterations in heart, including left ventricular dysfunction, fibrosis, ultimately heart failure, particularly presence coronary artery disease or hypertension. Autophagy, a critical cellular process for maintaining cardiac homeostasis, frequently disrupted cardiomyopathy. This review explores role autophagy pathogenesis high-fat diet (HFD) streptozotocin (STZ)-induced focusing on non-selective selective pathways, mitophagy, ER-phagy, ferritinophagy. Key proteins genes PINK1, Parkin, ULK1, AMPK, mTOR, ATG7, ATG5, Beclin-1, miR-34a are central to regulation Dysregulated autophagic flux impairs mitochondrial function, promotes oxidative stress, drives fibrosis heart. Additionally, processes lipophagy, regulated PNPLA8, ferritinophagy, modulated NCOA4, play pivotal roles lipid metabolism iron homeostasis. Emerging therapeutic strategies targeting autophagy, plant extracts (e.g., curcumin, dihydromyricetin), endogenous compounds sirtuin 3, LC3), lipid/glucose-lowering drugs, offer promising avenues mitigating effects Despite recent advances, precise mechanisms underlying this context remain poorly understood. A deeper understanding autophagy's regulatory networks, involving these proteins, may lead novel approaches treating

Язык: Английский

Процитировано

1

FBXL4 protects against HFpEF through Drp1-Mediated regulation of mitochondrial dynamics and the downstream SERCA2a DOI Creative Commons
Miyesaier Abudureyimu,

Xuanming Luo,

Lingling Jiang

и другие.

Redox Biology, Год журнала: 2024, Номер 70, С. 103081 - 103081

Опубликована: Фев. 9, 2024

Heart failure with preserved ejection fraction (HFpEF) is a devastating health issue although limited knowledge available for its pathogenesis and therapeutics. Given the perceived involvement of mitochondrial dysfunction in HFpEF, this study was designed to examine role dynamics etiology HFpEF.

Язык: Английский

Процитировано

6

Berberine Inhibits Ferroptosis and Stabilizes Atherosclerotic Plaque through NRF2/SLC7A11/GPX4 Pathway DOI
Tingting Wang,

Lili Yu,

Junmeng Zheng

и другие.

Chinese Journal of Integrative Medicine, Год журнала: 2024, Номер 30(10), С. 906 - 916

Опубликована: Авг. 21, 2024

Язык: Английский

Процитировано

4

SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established DOI Creative Commons

Adam Kia Shooshtarian,

Kevin O’Gallagher, Ajay M. Shah

и другие.

Heart Failure Reviews, Год журнала: 2025, Номер unknown

Опубликована: Янв. 23, 2025

Abstract With rising incidence, mortality and limited therapeutic options, heart failure with preserved ejection fraction (HFpEF) remains one of the most important topics in cardiovascular medicine today. Characterised by left ventricular diastolic dysfunction partially due to impaired Ca 2+ homeostasis, ion channel particular, SarcoEndoplasmic Reticulum -ATPase (SERCA2a), may play a significant role its pathophysiology. A better understanding complex mechanisms interplaying contribute SERCA2a will help develop treatments targeting it thus address growing clinical challenge HFpEF poses. This review examines conflicting evidence present for changes expression activity HFpEF, explores potential underlying mechanisms, finally evaluates drug gene therapy trials failure. Recent positive results from involving widely used anti-diabetic agents such as sodium-glucose co-transporter protein 2 inhibitors (SGLT2i) glucagon-like peptide-1 (GLP-1) agonists offer advancement management. The interplay between these regulation presents novel angle that could open new avenues modulating function; however, mechanistic research this emerging field is limited. Overall, direct undetermined, highlighting need well-designed pre-clinical studies robust trials.

Язык: Английский

Процитировано

0

Mitochondrial Quality Control: A Promising Target of Traditional Chinese Medicine in the Treatment of Cardiovascular Disease DOI Creative Commons
Deng Pan, Pengfei Chen, He Zhang

и другие.

Pharmacological Research, Год журнала: 2025, Номер unknown, С. 107712 - 107712

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Berberine improves cardiac insufficiency through AMPK/PGC-1α signaling-mediated mitochondrial homeostasis and apoptosis in HFpEF mice DOI
Yingchun Hu, Xiaoyu Chen, Qiming Zhao

и другие.

International Immunopharmacology, Год журнала: 2025, Номер 155, С. 114613 - 114613

Опубликована: Апрель 14, 2025

Язык: Английский

Процитировано

0

A High-Throughput Screening of a Natural Products Library for Mitochondria Modulators DOI Creative Commons
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick

и другие.

Biomolecules, Год журнала: 2024, Номер 14(4), С. 440 - 440

Опубликована: Апрель 4, 2024

Mitochondria, the energy hubs of cell, are progressively becoming attractive targets in search for potent therapeutics against neurodegenerative diseases. The pivotal role mitochondrial dysfunction pathogenesis various diseases, including Parkinson’s disease (PD), underscores urgency discovering novel therapeutic strategies. Given limitations associated with available treatments dysfunction-associated new alternatives has become imperative. In this report, we embarked on an extensive screening 4224 fractions from 384 Australian marine organisms and plant samples to identify natural products protective effects mitochondria. Our initial using PD patient-sourced olfactory neurosphere-derived (hONS) cells rotenone as a mitochondria stressor resulted 108 promising 11 different biota. To further assess potency efficacy these hits, biotas were subjected subsequent round human neuroblastoma (SH-SY5Y) cells, 6-hydroxydopamine induce stress, complemented by membrane potential assay. This rigorous process yielded 35 active eight biotas. Advanced analysis orbit trap mass spectrophotometer facilitated identification molecular constituents most fraction each meticulous approach led discovery 57 unique compounds, among which 12 previously recognized their mitoprotective effects. findings highlight vast derived plants quest innovative targeting

Язык: Английский

Процитировано

2

Insulin Resistance/Hyperinsulinemia, Neglected Risk Factor for the Development and Worsening of Heart Failure with Preserved Ejection Fraction DOI Creative Commons
Sergio Fazio, Valentina Mercurio,

Valeria Fazio

и другие.

Biomedicines, Год журнала: 2024, Номер 12(4), С. 806 - 806

Опубликована: Апрель 4, 2024

Heart failure (HF) has become a subject of continuous interest since it was declared new pandemic in 1997 because the exponential increase hospitalizations for HF latest years. is final state to which all heart diseases different etiologies lead if not adequately treated. It highly prevalent worldwide, with progressive age, reaching prevalence 10% subjects over age 65 During last two decades, possible see that preserved ejection fraction (HFpEF) increasing while reduced (HFrEF) decreasing. HFpEF typically characterized by concentric remodeling left ventricle (LV) impaired diastolic function and increased filling pressures. Over years, also insulin resistance (IR)/hyperinsulinemia (Hyperins) general adult population progressively increased, primarily due lifestyle changes, particularly developed developing countries, range globally ranges between 15.5% 46.5%. Notably, 50% patients have IR/Hyperins, percentage even higher those HFpEF. In scientific literature, been well highlighted circulating levels insulin, associated conditions resistance, are responsible cardiovascular alterations years could stimulate development and/or worsening The aim this manuscript review literature supports pathophysiologic connection IR/Hyperins community toward identification hyperinsulinemia as an independent risk factor HF, believing its adequate screening appropriate treatment reduce improve progression.

Язык: Английский

Процитировано

2

Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural fiber Interlaced liposomal technology DOI

Vedashree M. Sharma,

Themanamveedu Valsaraj,

Heggar Venkataramana Sudeep

и другие.

European Journal of Pharmaceutics and Biopharmaceutics, Год журнала: 2024, Номер 203, С. 114431 - 114431

Опубликована: Июль 31, 2024

Язык: Английский

Процитировано

1